Hard-earned insights that help drug manufacturers achieve their growth and profitability objectives.

Get helpful guidance delivered to your email immediately after we post.
Branded Prescription Drug Fee Payment Deadline Approaching

Branded Prescription Drug Fee Payment Deadline Approaching

Branded Prescription Drug Fee – Payment Deadline ApproachingFriendly reminder to all of our industry colleagues! The final Branded Prescription Drug Fee invoices should be mailed soon. No later than August 31st of each year, the IRS mails the final fee calculation to...

Part I Unwinding Medicaid Continuous Enrollment

Part I Unwinding Medicaid Continuous Enrollment

Part I – Unwinding Medicaid Continuous Enrollment May 2022After a slight decline from 2017 to 2019, Medicaid enrollment rose sharply throughout the pandemic. Historically, Medicaid enrollment tracks with unemployment rates. When rates rise, enrollment increases....

Update 2023 Best Price Accumulator Adjustment Program Ruling

Update 2023 Best Price Accumulator Adjustment Program Ruling

Update – 2023 Best Price & Accumulator Adjustment Program Ruling2023 was shaping up to be a year of challenging decisions for manufacturers and restricted access to critical pharmaceuticals for patients. The 2023 implementation of the proposed CMS Medicaid Best...

Letting Some Air Out of the AMP Inflation Penalty

Letting Some Air Out of the AMP Inflation Penalty

Letting some air out of the AMP inflation penalty.As of late, we have all been bombarded by headlines lamenting or explaining the recent high inflation rates as we consume our daily news. The default reaction to rising inflation is typically in relation to rising...

American Rescue Plan Act of 2021

American Rescue Plan Act of 2021

American Rescue Plan Act of 2021: Medicaid Rebate Inflation Penalties Will Soon Know No BoundsOn March 11, 2021, President Joe Biden signed into law the American Rescue Plan Act of 2021 (ARP21), also known as the COVID-19 Relief Bill. Many pharmaceutical manufacturers...